QNCX Stock Performance and Key Statistics

QNCX has a current P/E ratio of -3.4

The QNCX stock has a trailing twelve month price-to sales (P/S) ratio of 1183.23 while its price-to-book (P/B) value is 14.2.

QNCX's price-to-free-cashflow (P/FCF) ratio is -6.64, an indicator that is currently being trending upward.

Based on QNCX's recent bid, its distance from 20 days simple moving average is 0.99%. It is 44.1% apart from 50 days simple moving average, and it is 111.48% apart from 200 days simple moving average.

The 52-week high for QNCX is $4.55 which is -21.54% away from the current price level whereas the distance of that from the 52-week low of $0.72 stands at 395.63%.

The performance of QNCX stock was not encouraging with most of its significant price indicators in green. Quince Therapeutics, Inc.(NASDAQ: QNCX) shares have moved upward +2.59% or $0.09 in the latest trading session and have gained 90.91% year-to-date (YTD). The stock has gained nearly 75.86% over the past year. After moving 123.12% over the trailing 3-month period, the stock is 174.62% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -18.86% a week and 86.91% a month.

The current 14-day RSI for QNCX stock is 57.53. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Quince Therapeutics, Inc. (QNCX) has a 14-day ATR of 0.36.

After closing at $3.48 with 55.68M of its shares outstanding, the current enterprise value of QNCX is roughly 38.87M.

Quince Therapeutics, Inc. (NASDAQ: QNCX) is up 75.86% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 12.87%. QNCX stock price is also up 90.91% on its value in year-to-date trading.

The number outstanding shares of QNCX is 55.68M, and of these 83.38% shares are freely available for trading. On average, QNCX stock has traded 917.98K shares per day for the past 10 days. A total of 583.18K shares changed hands during the last trading session with the average session volume of 663.8K shares.